Ankit Agarwal, MD
Radiation Oncology · San Antonio
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 9 carriers
- Offices
- 25
Offices
25 locations · Western Radiation Oncology Inc · La Laser Center PC A Professional Medical Corporation · Urological Surgeons of Northern California Inc · Cancer Therapy Medical Group Inc · Vitalskin Medical Group Il PLLC · Owensboro Dermatology Associates Psc · Daniel Taheri MD PC · Oakview Dermatology · Piedmont Dermatology Center, PC
Hospitals listed: Santa Clara Valley Medical Center · Sutter Solano Medical Center. That is not proof they admit you there this week.
Plans that list them
36 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agarwal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A176205 · Current
Licensed to practise in California · since 2022 · expires 2028-02-29 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Sutter Solano Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.6 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.36 (106.6 to 218.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,268 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.7 (0.38 to 5.03) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.74 to 11.8) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.48) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 171 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.8 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 162 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.4) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.6 to 18.9) · 322 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (355 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$5,422,067
Medicare paid this office $5,422,067 for 984 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 335 | $764,097 | $234 |
| Use of externally generated heat to increase temperature of cancer cell, heating to depths 4.0 cm or less | 226 | $742,719 | $466 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 65 | $741,147 | $420 |
| Ultrasonic guidance for placement of radiation therapy fields | 659 | $559,024 | $159 |
| High dose rate electronic brachytherapy, external | 302 | $407,790 | $142 |
See all 37 services
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 335 | $764,097 | $234 |
| Use of externally generated heat to increase temperature of cancer cell, heating to depths 4.0 cm or less | 226 | $742,719 | $466 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 65 | $741,147 | $420 |
| Ultrasonic guidance for placement of radiation therapy fields | 659 | $559,024 | $159 |
| High dose rate electronic brachytherapy, external | 302 | $407,790 | $142 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 492 | $249,614 | $422 |
| Ct guidance for insertion of radiation therapy fields | 65 | $231,829 | $133 |
| Injection of biodegradable material next to prostate | 62 | $193,724 | $3,125 |
| High precision radiation therapy planning | 72 | $185,069 | $2,079 |
| Complex radiation therapy planning for delivery of internal radiation | 193 | $131,311 | $476 |
| Calculation of radiation therapy dose | 135 | $89,179 | $71 |
| Design and construction of radiation treatment device for high precision radiation therapy | 74 | $80,585 | $513 |
| Radiation treatment management, 5 treatment sessions | 65 | $73,409 | $187 |
| New patient visit (60+ min) | 210 | $40,416 | $192 |
| Complex application of radiation source | 103 | $40,062 | $389 |
| Continuing radiation therapy consultation per week | 71 | $37,240 | $103 |
| Complex radiation therapy planning | 209 | $32,766 | $150 |
| Special medical radiation therapy consultation | 176 | $32,721 | $155 |
| Return visit (30+ min) | 197 | $27,429 | $114 |
| Special radiation treatment | 171 | $23,216 | $136 |
| Insertion of needle or tube into prostate for radiation therapy | 33 | $20,882 | $633 |
| 3d radiation therapy planning | 107 | $20,463 | $191 |
| New patient visit (45+ min) | 111 | $16,108 | $143 |
| High precision radiation therapy planning | 26 | $14,370 | $388 |
| Calculation of radiation therapy dose | 31 | $11,604 | $30 |
| Design and construction of complex radiation treatment device | 59 | $8,203 | $137 |
| Design and construction of radiation treatment device for high precision radiation therapy | 26 | $7,929 | $209 |
| Superficial and/or low voltage radiation treatment delivery | 28 | $7,106 | $33 |
| Ultrasonic guidance for administration of radiation therapy | 104 | $5,874 | $56 |
| Short return visit (20+ min) | 42 | $4,007 | $83 |
| Long return visit (40+ min) | 13 | $3,691 | $168 |
| Simple radiation therapy planning | 58 | $3,459 | $59 |
| Design and construction of complex radiation treatment device | 11 | $2,745 | $56 |
| Design and construction of simple radiation treatment device | 103 | $2,082 | $20 |
| Design and construction of simple radiation treatment device | 65 | $2,050 | $31 |
| Complex radiation therapy planning | 11 | $1,689 | $154 |
| Intermediate radiation therapy planning | 14 | $1,260 | $90 |
Who their Medicare patients are
984 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 11% · Women 24% · Also on Medicaid 10% · Health risk score 1.17. At or below the middle of the specialty; the typical radiation oncology clinician is at 1.69.
Conditions among them: High blood pressure 75% · Cancer 57% · Diabetes 32% · Coronary heart disease 29% · Chronic kidney disease 23% · Atrial fibrillation 20% · Heart failure 14% · COPD 12% · Depression 12% · Stroke 7% · Dementia 4%.
The office billed $16,514,608, Medicare allowed $6,739,275 and paid $5,422,067; for 23,399 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 984 | 23,399 | 75 | 1.17 | $16,514,608 | $5,422,067 |
| 2023 | 307 | 2,161 | 75 | 1.09 | $2,502,104 | $668,524 |
| 2022 | 153 | 677 | 76 | 1.76 | $776,230 | $139,953 |
| 2021 | 280 | 810 | 73 | 1.39 | $324,384 | $80,995 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Injection of biodegradable material next to prostate | 31 | $102,335 | $3,301 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 136 | $100,519 | $500 |
| Complex radiation therapy planning for delivery of internal radiation | 129 | $94,510 | $492 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 20 | $55,965 | $376 |
| High precision radiation therapy planning | 26 | $51,666 | $1,987 |
| Complex application of radiation source | 78 | $31,197 | $400 |
| Ultrasonic guidance for placement of radiation therapy fields | 123 | $26,702 | $201 |
| New patient visit (60+ min) | 126 | $25,440 | $202 |
| Special medical radiation therapy consultation | 127 | $24,984 | $155 |
| Complex radiation therapy planning | 126 | $20,353 | $159 |
| Ct guidance for insertion of radiation therapy fields | 20 | $17,898 | $111 |
| Insertion of needle or tube into prostate for radiation therapy | 27 | $17,120 | $634 |
| Special radiation treatment | 118 | $16,491 | $139 |
| 3d radiation therapy planning | 77 | $15,310 | $199 |
| Design and construction of radiation treatment device for high precision radiation therapy | 27 | $14,431 | $481 |
| Radiation treatment management, 5 treatment sessions | 21 | $9,124 | $172 |
| Calculation of radiation therapy dose | 28 | $8,503 | $69 |
| Return visit (30+ min) | 55 | $7,261 | $125 |
| Ultrasonic guidance for administration of radiation therapy | 75 | $4,402 | $59 |
| Continuing radiation therapy consultation per week | 13 | $2,224 | $89 |
| New patient visit (45+ min) | 12 | $1,933 | $161 |
| Design and construction of simple radiation treatment device | 78 | $1,645 | $21 |
2022: 18 services
| Injection of biodegradable material next to prostate | 15 | $46,326 | $3,088 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 16 | $10,344 | $493 |
| Complex radiation therapy planning for delivery of internal radiation | 16 | $9,887 | $471 |
| Complex application of radiation source | 15 | $5,875 | $392 |
| New patient visit (60+ min) | 29 | $5,837 | $201 |
| Ct guidance for insertion of radiation therapy fields | 28 | $5,541 | $39 |
| Radiation treatment management, 5 treatment sessions | 15 | $5,375 | $168 |
| 3d radiation therapy planning | 17 | $3,493 | $194 |
| Special medical radiation therapy consultation | 16 | $2,973 | $142 |
| Design and construction of radiation treatment device for high precision radiation therapy | 11 | $2,830 | $202 |
| Complex radiation therapy planning | 15 | $2,290 | $153 |
| Complex radiation therapy planning | 12 | $2,091 | $149 |
| Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | 18 | $1,893 | $86 |
| Special radiation treatment | 14 | $1,833 | $131 |
| Radiation treatment management, 5 treatment sessions | 11 | $1,602 | $146 |
| New patient visit (45+ min) | 12 | $1,460 | $122 |
| Design and construction of complex radiation treatment device | 12 | $1,349 | $54 |
| Design and construction of simple radiation treatment device | 21 | $439 | $21 |
2021: 12 services
| Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | 62 | $10,466 | $90 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 11 | $6,867 | $286 |
| Radiation treatment management, 5 treatment sessions | 37 | $5,791 | $148 |
| Ct guidance for insertion of radiation therapy fields | 75 | $5,218 | $35 |
| Radiation treatment management, 5 treatment sessions | 30 | $4,581 | $148 |
| Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | 20 | $3,428 | $90 |
| Complex radiation therapy planning | 23 | $3,031 | $132 |
| New patient visit (60+ min) | 18 | $2,604 | $145 |
| Design and construction of radiation treatment device for high precision radiation therapy | 14 | $2,468 | $176 |
| Design and construction of complex radiation treatment device | 30 | $2,363 | $47 |
| Calculation of radiation therapy dose | 13 | $1,251 | $26 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 13 | $834 | $64 |
Drugs they prescribed that Part D paid
$234,576
Pharmacies billed $234,576 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 448) in 2024. At or below the middle of the specialty; the typical radiation oncology clinician is at 11%.
356 generic and fewer than 11 brand-name prescriptions · $234,576 in drug cost · 65 antibiotic prescriptions to 60 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Orgovyx | 13 | $229,245 | $2,697 |
| Tamsulosin | 88 | $2,477 | $13 |
| Bicalutamide | 13 | $350 | $27 |
| Methylprednisolone | 20 | $219 | $8 |
| Oxybutynin Chloride | 14 | $140 | $6 |
See all 6 drugs
| Orgovyx | 13 | $229,245 | $2,697 |
| Tamsulosin | 88 | $2,477 | $13 |
| Bicalutamide | 13 | $350 | $27 |
| Methylprednisolone | 20 | $219 | $8 |
| Oxybutynin Chloride | 14 | $140 | $6 |
| Sulfamethoxazole-Trimethoprim | 53 | $89 | $2 |
Year by year
| 2024 | 448 | 185 | 0% (0) | None | $234,576 |
| 2023 | 140 | 81 | None | None | $8,689 |
| 2022 | 49 | 28 | None | None | $1,059 |
| 2021 | 52 | 30 | None | None | $1,977 |
| 2020 | 82 | 28 | 16% (13) | None | $2,331 |
| 2019 | 123 | 51 | None | 10% | $3,470 |
| 2018 | 110 | 59 | None | None | $11,539 |
| 2017 | 164 | 57 | 7% (12) | None | $18,078 |
| 2016 | 157 | 25 | None | None | $12,666 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Tamsulosin | 62 | $1,410 | $23 |
| Rosuvastatin | 12 | $403 | $34 |
| Methylprednisolone | 15 | $102 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $34 | $2 |
2022: 1 drug
| Tamsulosin | 15 | $349 | $23 |
2021: 1 drug
| Tamsulosin | 18 | $534 | $30 |
2020: 1 drug
| Tamsulosin | 12 | $205 | $17 |
2019: 2 drugs
| Tamsulosin | 43 | $973 | $23 |
| Bicalutamide | 14 | $637 | $46 |
2018: 3 drugs
| Tamsulosin | 48 | $1,591 | $33 |
| Bicalutamide | 16 | $901 | $56 |
| Lidocaine Hcl Viscous | 15 | $102 | $7 |
2017: 1 drug
| Tamsulosin | 16 | $597 | $37 |
Money from drug and device companies
$1,156 in 2025
| 2025 | 6 | 14 | $350 | $1,156 |
| 2024 | 7 | 19 | None | $900 |
| 2023 | 4 | 8 | None | $667 |
| 2022 | 5 | 12 | None | $883 |
| 2019 | 1 | 1 | None | $485 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teleflex | Barrigel | $915 | 6 payments
|
| Revance Therapeutics | Daxxify | $120 | 3 payments
|
| Telix Pharmaceuticals | Illuccix | $57 | 2 payments
|
| Sumitomo Pharma America | Orgovyx | $30 | 1 payment
|
| Pfizer | Xtandi | $18 | 1 payment
|
| Avanos Medical | None | $16 | 1 payment
|
See all 14 published payments
| Teleflex | Honoraria · 2025-11-14 | Barrigel | $350 |
| Teleflex | Meals · 2025-11-12 | Barrigel | $64 |
| Revance Therapeutics | Meals · 2025-09-16 | Daxxify | $26 |
| Revance Therapeutics | Meals · 2025-09-09 | Daxxify | $19 |
| Revance Therapeutics | Meals · 2025-09-05 | Daxxify | $75 |
| Telix Pharmaceuticals | Meals · 2025-08-29 | Illuccix | $29 |
| Teleflex | Meals · 2025-08-28 | Barrigel | $191 |
| Teleflex | Meals · 2025-07-07 | Barrigel | $28 |
| Sumitomo Pharma America | Meals · 2025-05-20 | Orgovyx | $30 |
| Teleflex | Meals · 2025-05-05 | Barrigel | $123 |
| Avanos Medical | Meals · 2025-04-22 | None | $16 |
| Telix Pharmaceuticals | Meals · 2025-02-28 | Illuccix | $29 |
| Teleflex | Meals · 2025-02-12 | Barrigel | $159 |
| Pfizer | Meals · 2025-01-30 | Xtandi | $18 |
See earlier years (2024, 2023, 2022, 2019)
2024: $900
| Telix Pharmaceuticals | Illuccix | $285 | 8 payments
|
| Theragenics | None | $246 | 4 payments
|
| Teleflex | None | $124 | 1 payment
|
| Bioprotect Medical | Bioprotect Balloon Implant System | $111 | 3 payments
|
| Medtronic | Venaseal | $82 | 1 payment
|
| Tempus AI | None | $30 | 1 payment
|
| Siemens Medical Solutions USA | Bravos Afterloader System | $22 | 1 payment
|
2023: $667
| Siemens Medical Solutions USA | Varian Ethos Treatment Planning | $305 | 4 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $203 | 2 payments
|
| Palette Life Sciences | None | $144 | 1 payment
|
| Accord Healthcare | Camcevi | $15 | 1 payment
|
2022: $883
| Palette Life Sciences | None | $456 | 5 payments
|
| Theragenics | None | $138 | 2 payments
|
| Siemens Medical Solutions USA | Halcyon | $115 | 2 payments
|
| IsoRay | Brachytherapy Source | $103 | 2 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $70 | 1 payment
|
2019: $485
| RaySearch Laboratories AB (publ) | None | $485 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Siemens Medical Solutions USA, Inc. · Daily Adaptive Stereotactic Body Radiation Therapy for Prostate Cancer With Urethral Sparing: A Prospective Trial Using An Individualized Approach To · 2024 | Their institution | $14,126 |
Professional record
- NPI
- 1629430376
- Licence
- CA A176205, MA 267318, NC 1629430376California A176205: Current · expires 2028-02-29
- Group
- Western Radiation Oncology Inc · La Laser Center PC A Professional Medical Corporation · Urological Surgeons of Northern California Inc · Cancer Therapy Medical Group Inc · Vitalskin Medical Group Il PLLC · Owensboro Dermatology Associates Psc · Daniel Taheri MD PC · Oakview Dermatology · Piedmont Dermatology Center, PC
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X); Federal specialty code 2085R0203X (2085R0203X)
- Mailing address
- 125 South Dr, Mountain View, CA, 94040
- NPI first listed
- 2016-03-22
- NPI last updated
- 2026-08-12
- NPI record certified
- 2026-08-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 125 South Dr, Mountain View, CA, 94040